首页> 外文期刊>Immunity Ageing >Gene and protein expression of CXCR4 in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations
【24h】

Gene and protein expression of CXCR4 in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations

机译:成人和老年慢性鼻炎,咽炎或鼻窦炎接受热水鼻吸入治疗的CXCR4基因和蛋白表达

获取原文
       

摘要

BackgroundChronic rhinitis, pharyngitis and sinusitis are common health problems with a significant impact on public health, and are suspected to be influenced by ageing factors. Nasal inhalation with thermal water may be used to reduce symptoms, inflammation and drug intake. A pre-post clinical study was conducted in 183 consecutive adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis, to evaluate whether thermal water nasal inhalations could improve their symptoms, clinical signs and rhinomanometry measurements, and influence inflammatory biomarkers levels in nasal epithelial cells. ResultsParticipants profile revealed that they were aged on average (mean age and SD 60.6?±?15.2?years, median 65, range 20–86, 86 aged ≤?65?years (47%), 96 aged >?65?years (53%)) and extremely concerned about wellbeing. Older age was associated with better compliance to inhalation treatment. Total symptom and clinical evaluation scores were significantly ameliorated after treatment ( p ConclusionsThese results confirm the clinical impact of thermal water nasal inhalations on upper respiratory diseases both in adults and elders, and emphasize the role of genes activating tissue repair and inflammatory pathways. Future studies should evaluate CXCR4 as possible therapeutic target or response predictor in patients with chronic rhinitis, pharyngitis or sinusitis. Trial registrationCommunication to Italian Ministry of Health - ICPOM 000461. Registered 10/11/2014.
机译:背景慢性鼻炎,咽炎和鼻窦炎是常见的健康问题,对公共健康有重大影响,并被怀疑受衰老因素的影响。可以用热水将鼻吸入,以减轻症状,减轻炎症和减少药物摄入。在连续的183名成年和老年慢性鼻炎,咽炎或鼻窦炎患者中进行了一项临床前研究,以评估鼻腔吸入热水是否可以改善其症状,临床体征和鼻压测量,并影响鼻上皮细胞的炎症生物标志物水平。结果参与者资料显示,他们平均年龄(平均年龄和SD 60.6?±?15.2?岁,中位数65岁,范围20-86,≤65岁的年龄为86岁(47%),> 65岁的年龄为96岁( 53%)),并非常关注健康状况。年龄较大与更好的吸入治疗依从性有关。治疗后总症状和临床评估得分得到明显改善(p结论)这些结果证实了鼻吸热水对成年人和老年人上呼吸道疾病的临床影响,并强调了基因激活组织修复和炎性途径的作用。评估CXCR4作为慢性鼻炎,咽炎或鼻窦炎患者可能的治疗靶点或反应预测因子的方法意大利卫生部注册注册通讯-ICPOM 000461.注册时间:2014/11/10。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号